Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Papers of the Week
Annotation


Paleologou KE, Oueslati A, Shakked G, Rospigliosi CC, Kim HY, Lamberto GR, Fernandez CO, Schmid A, Chegini F, Gai WP, Chiappe D, Moniatte M, Schneider BL, Aebischer P, Eliezer D, Zweckstetter M, Masliah E, Lashuel HA. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions. J Neurosci. 2010 Mar 3;30(9):3184-98. PubMed Abstract

  
Comments on Paper and Primary News
  Primary News: Synuclein Modifications: Caveat Emptor With Those Phosphomimetics

Comment by:  Junchao Tong
Submitted 15 March 2010  |  Permalink Posted 18 March 2010

I'd like to post a correction to a mistake in this article: the difference in amino acid sequence of alpha-synuclein between human and rat/mouse is 7, not 5. These include A53T, S87N, L100M, N103G, A107Y, D121S/G, and N122S. The sequences were from GenBank: human, NP000336.1; rat, NP062042.1; mice, NP033247.1

View all comments by Junchao Tong

  Primary News: Synuclein Modifications: Caveat Emptor With Those Phosphomimetics

Comment by:  Andrew Doig (Disclosure)
Submitted 24 March 2010  |  Permalink Posted 24 March 2010

I have never found the concept of mimicking phosphoserine with glutamate convincing. Glutamate lacks an oxygen and cannot have a doubly negative charge, unlike phosphoserine. Aspartate, which is often also used to replace phosphoserine, is even worse, as it is one bond shorter. If the protein or peptide is short enough, it can be synthesized using a phosphorylated amino acid.

View all comments by Andrew Doig
  Submit a Comment on this Paper
Cast your vote and/or make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend this paper

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
 
 

REAGENTS/MATERIAL:
Immunocytochemistry, S87-P in transgenic mice: To investigate the distribution of the phosphorylated α-syn epitopes brains from non-TG and TG mice, seriallysectioned, free-floating, blind-coded vibratome sections were incubated overnight at 4°C with either the mouse monoclonal anti-α-syn (42) (Transduction Laboratories), rabbit anti-human α-syn (Millipore Bioscience Research Reagents), mouse monoclonal anti-S129-P α-syn (pSyn 64) (Waco Chemical Industries) and the rabbit polyclonal anti-S87-P α-syn, as described previously (Masliah et al., 2000).
Analysis of injected rat brains, Immunofluorescence: Slices were incubated overnight at 4°C with rabbit anti-tyrosine hydroxylase (Millipore) and mouse monoclonal anti-Human α-syn (LB509) (Zymed Laboratories) antibodies in blocking buffer and subsequently incubated for 2 h at room temperature with secondary antibodies conjugated to Alexa Fluor-488 or Alexa Fluor-568. Slices were incubated overnight at 4°C with the primary antibody anti-P Ser 87.
Double labeling and confocal microscopy: To determine the colocalization between α-syn-immunolabeled neurons and CK1, 40-μm-thick vibratome sections from α-syn TG mice were immunolabeled with the rabbit polyclonal anti-α-syn (Millipore Bioscience Research Reagents) and polyclonal anti-CK1δ (C-18) (Santa Cruz Biotechnology).
Detection of S87-P in Lewy bodies: Lewy body enrichment was conducted as previously described (Gai et al., 2000). Primary antibodies were affinity-purified sheep anti-α-syn (Gai et al., 1999), affinity purified rabbit anti-S87-P α-syn, and mouse monoclonal anti-pS129 α-syn (11A5) (Anderson et al., 2006).
In vitro phosphorylation and dephosphorylation assays: The progress of the phosphorylation reaction was monitored by Western blot using antibodies against S87-P and S129-P.
Gel electrophoresis (SDS-PAGE) and immunoblotting: α-Syn samples were diluted in loading buffer and separated on 12% SDS 1 mm gel. Gels were stained with Simply Blue Safe stain (Invitrogen) or silver stained (Invitrogen) according to manufacturer’s instructions. For Western blots, membranes were probed with mouse monoclonal anti-α-syn (121–125) (211) (Santa Cruz Biotechnology) or mouse monoclonal anti-α-syn (15–123) (42) (BD Transduction), or mouse monoclonal anti-S129-P α-syn (pSyn64) (Wako), or rabbit polyclonal anti-S87-P α-syn. Western blot analysis for brain homogenates used the following primary antibodies: rabbit polyclonal anti-total α-syn (Millipore Bioscience Research Reagents), mouse monoclonal anti-S129-P α-syn (courtesy of Dr. T. Iwatsubo, University of Tokyo, Tokyo, Japan), rabbit polyclonal anti-S87-P α-syn and mouse monoclonal anti-α-actin (ASM-1) (Millipore Bioscience Research Reagents).

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad